Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis

por Walsh, Jessica A., Saffore, Christopher D., Collins, Eric B., Ostor, Andrew
Publicado 2023

Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States

por Bergman, Martin, Patel, Pankaj, Chen, Naijun, Jing, Yonghua, Saffore, Christopher D.
Publicado 2020

Geographic Variations in Diagnosis and Treatment of Ankylosing Spondylitis in the United States: A Real-World Study

por Deodhar, Atul, Kruzikas, Denise, Zhou, Lili, Biljan, Ana, Saffore, Christopher D.
Publicado 2021

Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA

por Ogdie, Alexis, Matthias, Wesley, Thielen, Richard J., Chin, Daniel, Saffore, Christopher D.
Publicado 2021

Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis

por Bergman, Martin, Saffore, Christopher D., Kim, Katherine J., Patel, Pankaj A., Garg, Vishvas, Xuan, Si, Naik, Haley B.
Publicado 2021

Development of a measure of prescriber satisfaction with academic detailing: the PSAD

por Monteiro, Andrea L, Smart, Mary, Saffore, Christopher D, Lee, Todd A, Tilton, Sarette T, Fischer, Michael A, Pickard, A Simon
Publicado 2022

Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry

por Bergman, Martin J., Zueger, Patrick, Patel, Jayeshkumar, Saffore, Christopher D., Topuria, Ia, Cavanaugh, Cristi, Fang, Siran, Clewell, Jerry, Ogdie, Alexis
Publicado 2022

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis

por Navarro-Compán, Victoria, Baraliakos, Xenofon, Magrey, Marina, Östör, Andrew, Saffore, Christopher D., Mittal, Manish, Song, In-Ho, Ganz, Fabiana, Stigler, Jayne, Deodhar, Atul
Publicado 2023

Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2

por Kiltz, Uta, Kishimoto, Mitsumasa, Walsh, Jessica A., Sampaio-Barros, Percival, Mittal, Manish, Saffore, Christopher D., Wung, Peter, Ganz, Fabiana, Biljan, Ana, Poddubnyy, Denis
Publicado 2023

Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2

por Strand, Vibeke, Van den Bosch, Filip, Ranza, Roberto, Leung, Ying-Ying, Drescher, Edit, Zueger, Patrick, Saffore, Christopher D., Lertratanakul, Apinya, Lippe, Ralph, Nash, Peter
Publicado 2021

Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1

por Strand, Vibeke, Mease, Philip J., Soriano, Enrique R., Kishimoto, Mitsumasa, Salvarani, Carlo, Saffore, Christopher D., Zueger, Patrick, McDearmon-Blondell, Erin, Kato, Koji, Gladman, Dafna D.
Publicado 2021

Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults

por Guadamuz, Jenny S., Ozenberger, Katharine, Qato, Dima M., Ko, Naomi Y., Saffore, Christopher D., Adimadhyam, Sruthi, Cha, Ashley S., Moran, Kellyn M., Sweiss, Karen, Patel, Pritesh R., Chiu, Brian C.-H., Calip, Gregory S.
Publicado 2019